Quick Answer
Aspira Women's Health Inc. reported Net Income Loss of -$13.09 million for the year ending 2024.
- Aspira Women's Health Inc. showed an increase of +21.5% in Net Income Loss from 2023 to 2024.
- This data is from Aspira Women's Health Inc.'s annual report (Form 10-K), filed with the SEC on March 27, 2025.
- XBRL data for this metric is available from 2010 to 2024 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 15 years of available data (2010 to 2024), Aspira Women's Health Inc.'s Net Income Loss has grown by 31.2%.
- Historical annual values: Fiscal year 2024: -$13.09 million | Fiscal year 2023: -$16.69 million | Fiscal year 2022: -$29.89 million | Fiscal year 2021: -$31.66 million | Fiscal year 2020: -$17.91 million | Fiscal year 2019: -$15.24 million | Fiscal year 2018: -$11.37 million | Fiscal year 2017: -$10.50 million | Fiscal year 2016: -$14.97 million | Fiscal year 2015: -$19.12 million | Fiscal year 2014: -$19.21 million | Fiscal year 2013: -$8.82 million | Fiscal year 2012: -$7.15 million | Fiscal year 2011: -$17.79 million | Fiscal year 2010: -$19.03 million.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: